Eli Lilly Drug Shows Significant Weight Loss in New Studies
Retatrutide, which targets three weight-related hormones, led to substantial reductions in body weight in individuals with and without Type 2 diabetes.
Retatrutide, which targets three weight-related hormones, led to substantial reductions in body weight in individuals with and without Type 2 diabetes.
Novo Nordisk's CagriSema demonstrated greater weight loss and improved blood sugar control compared to tirzepatide in a clinical trial involving patients with type 2 diabetes.
Health officials warn of increased Vibrio vulnificus infections linked to warmer waters.
New research indicates women using popular obesity and diabetes drugs can conceive without increasing risks of miscarriage or birth defects.
Experts suggest cooking with cast iron can contribute to daily iron consumption, particularly for those at risk of deficiency.
Experimental vaccines are teaching the immune system to fight cancer, with early trials showing significant success for patients with previously difficult-to-treat diseases.
New research suggests shorter periods of vigorous exercise could significantly reduce the risk of early death and enhance immune function.
Experts suggest the oral medication, which combines naltrexone and bupropion, could be a more accessible and effective option for certain individuals struggling with weight management, particularly those with binge-eating disorders.
A significant portion of cancer cases worldwide are linked to preventable infections, with a new study highlighting the need for improved vaccination and infection control strategies.